ORIGINAL RESEARCH article
Front. Allergy
Sec. Asthma
Volume 6 - 2025 | doi: 10.3389/falgy.2025.1593351
This article is part of the Research TopicThe Intersection of Cardiovascular Disease and Asthma: Emphasizing Women's Health and Mechanistic InsightsView all articles
Platelet-to-High-Density Lipoprotein Ratio as a Biomarker for Asthma Risk in Adolescents: Insights from NHANES 2011-2023
Provisionally accepted
- Putuo District Central Hospital, Shanghai, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
AbstractBackground:Asthma is a common inflammatory disease among adolescents, with systemic inflammation playing a key role in its development. The platelet-to-high-density lipoprotein ratio (PHR) has emerged as a novel indicator of systemic inflammation. However, while individual roles of platelet count and HDL cholesterol in asthma have been studied, the combined impact of PHR on asthma risk—particularly in adolescent populations—remains unclear and underexplored.Objective:This study aimed to evaluate the association between PHR and asthma risk in adolescents using data from the National Health and Nutrition Examination Survey (NHANES) 2011–2023.Methods:A cross-sectional analysis was conducted on 10,046 adolescents aged 8–18 years from NHANES. Asthma status was self-reported, and PHR was calculated as the ratio of platelet count (1033/μL) to HDL cholesterol (mg/dL). Logistic regression models were used to assess the association between PHR quartiles and asthma, adjusting for age, sex, race/ethnicity, body mass index (BMI), and poverty-to-income ratio (PIR). Restricted cubic spline (RCS) analysis was applied to examine non-linear relationships, with sensitivity and subgroup analyses conducted to ensure robustness.Results:Adolescents with asthma had higher PHR levels compared to non-asthmatic peers (p < 0.001). In fully adjusted models, participants in the highest PHR quartile had significantly higher odds of asthma (OR = 1.59, 95% CI: 1.37–1.83, p < 0.001) compared to the lowest quartile. RCS analysis revealed a non-linear relationship, with asthma risk escalating sharply at higher PHR levels. Subgroup analyses confirmed consistent associations across race/ethnicity, BMI, and PIR categories. Sensitivity analyses excluding participants under 12 years of age yielded similar results.Conclusion:PHR is significantly associated with asthma risk in adolescents, highlighting its potential as a cost-effective and accessible biomarker for identifying high-risk individuals. These findings underscore the need for further longitudinal and interventional studies to validate PHR’s role in asthma prediction and management.Keywords:Asthma, Adolescents, Platelet-to-HDL Ratio (PHR), Systemic Inflammation, Biomarker, NHANES
Keywords: Asthma, adolescents, Platelet-to-HDL Ratio (PHR), systemic inflammation, biomarker, NHANES
Received: 17 Mar 2025; Accepted: 20 May 2025.
Copyright: © 2025 Liao, Lv, Xu, Zan and Xie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yu Xie, Putuo District Central Hospital, Shanghai, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.